118 related articles for article (PubMed ID: 21262309)
21. A genetically engineered spleen necrosis virus-derived retroviral vector that displays the HIV type 1 glycoprotein 120 envelope peptide.
Jiang A; Fisher H; Pomerantz RJ; Dornburg R
Hum Gene Ther; 1999 Nov; 10(16):2627-36. PubMed ID: 10566890
[TBL] [Abstract][Full Text] [Related]
22. Suppression of CCR5-tropic HIV type 1 infection by OX40 stimulation via enhanced production of β-chemokines.
Tanaka R; Takahashi Y; Kodama A; Saito M; Ansari AA; Tanaka Y
AIDS Res Hum Retroviruses; 2010 Oct; 26(10):1147-54. PubMed ID: 20854204
[TBL] [Abstract][Full Text] [Related]
23. Rapid induction of OX40 ligand on primary T cells activated under DNA-damaging conditions.
Kondo K; Okuma K; Tanaka R; Matsuzaki G; Ansari AA; Tanaka Y
Hum Immunol; 2008 Sep; 69(9):533-42. PubMed ID: 18718855
[TBL] [Abstract][Full Text] [Related]
24. OX40 is differentially expressed on activated rat and mouse T cells and is the sole receptor for the OX40 ligand.
al-Shamkhani A; Birkeland ML; Puklavec M; Brown MH; James W; Barclay AN
Eur J Immunol; 1996 Aug; 26(8):1695-9. PubMed ID: 8765008
[TBL] [Abstract][Full Text] [Related]
25. Breast milk CD4+ T cells express high levels of C chemokine receptor 5 and CXC chemokine receptor 4 and are preserved in HIV-infected mothers receiving highly active antiretroviral therapy.
Kourtis AP; Ibegbu CC; Theiler R; Xu YX; Bansil P; Jamieson DJ; Lindsay M; Butera S; Duerr A
J Infect Dis; 2007 Apr; 195(7):965-72. PubMed ID: 17330786
[TBL] [Abstract][Full Text] [Related]
26. A novel mechanism for HIV1-mediated bystander CD4+ T-cell death: neighboring dying cells drive the capacity of HIV1 to kill noncycling primary CD4+ T cells.
Lelièvre JD; Mammano F; Arnoult D; Petit F; Grodet A; Estaquier J; Ameisen JC
Cell Death Differ; 2004 Sep; 11(9):1017-27. PubMed ID: 15118766
[TBL] [Abstract][Full Text] [Related]
27. Enhancement of OX40-induced apoptosis by TNF coactivation in OX40-expressing T cell lines in vitro leading to decreased targets for HIV type 1 production.
Takahashi Y; Tanaka R; Yamamoto N; Tanaka Y
AIDS Res Hum Retroviruses; 2008 Mar; 24(3):423-35. PubMed ID: 18327975
[TBL] [Abstract][Full Text] [Related]
28. Modulation of specific surface receptors and activation sensitization in primary resting CD4+ T lymphocytes by the Nef protein of HIV-1.
Keppler OT; Tibroni N; Venzke S; Rauch S; Fackler OT
J Leukoc Biol; 2006 Mar; 79(3):616-27. PubMed ID: 16365153
[TBL] [Abstract][Full Text] [Related]
29. OX40 ligation of CD4+ T cells enhances virus-specific CD8+ T cell memory responses independently of IL-2 and CD4+ T regulatory cell inhibition.
Yu Q; Yue FY; Gu XX; Schwartz H; Kovacs CM; Ostrowski MA
J Immunol; 2006 Feb; 176(4):2486-95. PubMed ID: 16456009
[TBL] [Abstract][Full Text] [Related]
30. OX40 ligand expressed in glioblastoma modulates adaptive immunity depending on the microenvironment: a clue for successful immunotherapy.
Shibahara I; Saito R; Zhang R; Chonan M; Shoji T; Kanamori M; Sonoda Y; Kumabe T; Kanehira M; Kikuchi T; So T; Watanabe T; Takahashi H; Iwabuchi E; Tanaka Y; Shibahara Y; Sasano H; Ishii N; Tominaga T
Mol Cancer; 2015 Feb; 14():41. PubMed ID: 25744203
[TBL] [Abstract][Full Text] [Related]
31. OX40 stimulation by gp34/OX40 ligand enhances productive human immunodeficiency virus type 1 infection.
Takahashi Y; Tanaka Y; Yamashita A; Koyanagi Y; Nakamura M; Yamamoto N
J Virol; 2001 Aug; 75(15):6748-57. PubMed ID: 11435553
[TBL] [Abstract][Full Text] [Related]
32. Study on the expression of co-stimulatory marker CD134 on CD4+ T cells in HIV-1-infected individuals.
Palanee A; Pattarawat T
J Immunoassay Immunochem; 2012; 33(2):195-202. PubMed ID: 22471609
[TBL] [Abstract][Full Text] [Related]
33. Functional CD4 T cells after intercellular molecular transfer of 0X40 ligand.
Baba E; Takahashi Y; Lichtenfeld J; Tanaka R; Yoshida A; Sugamura K; Yamamoto N; Tanaka Y
J Immunol; 2001 Jul; 167(2):875-83. PubMed ID: 11441094
[TBL] [Abstract][Full Text] [Related]
34. HIV-1 requires Arf6-mediated membrane dynamics to efficiently enter and infect T lymphocytes.
García-Expósito L; Barroso-González J; Puigdomènech I; Machado JD; Blanco J; Valenzuela-Fernández A
Mol Biol Cell; 2011 Apr; 22(8):1148-66. PubMed ID: 21346189
[TBL] [Abstract][Full Text] [Related]
35. OX40-OX40L expression in idiopathic inflammatory myopathies.
Papadopoulos C; Terzis G; Papadimas GK; Manta P
Anal Quant Cytopathol Histpathol; 2013 Feb; 35(1):17-26. PubMed ID: 23469620
[TBL] [Abstract][Full Text] [Related]
36. Metabolically active CD4+ T cells expressing Glut1 and OX40 preferentially harbor HIV during in vitro infection.
Palmer CS; Duette GA; Wagner MCE; Henstridge DC; Saleh S; Pereira C; Zhou J; Simar D; Lewin SR; Ostrowski M; McCune JM; Crowe SM
FEBS Lett; 2017 Oct; 591(20):3319-3332. PubMed ID: 28892135
[TBL] [Abstract][Full Text] [Related]
37. Direct demonstration of CD4 T cell cooperation in the primary in vivo generation of CD4 effector T cells.
Kroeger DR; Rudulier CD; Peters NC; Bretscher PA
Int Immunol; 2012 Aug; 24(8):519-27. PubMed ID: 22527289
[TBL] [Abstract][Full Text] [Related]
38. Critical role of OX40/OX40L in ILC2-mediated activation of CD4
Wu J; Cui Y; Zhu W; Bai S; Zhao N; Liu B
Int Immunopharmacol; 2019 Nov; 76():105784. PubMed ID: 31470268
[TBL] [Abstract][Full Text] [Related]
39. Resistance against syncytium-inducing human immunodeficiency virus type 1 (HIV-1) in selected CD4(+) T cells from an HIV-1-infected nonprogressor: evidence of a novel pathway of resistance mediated by a soluble factor(s) that acts after virus entry.
Saha K; Volsky DJ; Matczak E
J Virol; 1999 Sep; 73(9):7891-8. PubMed ID: 10438887
[TBL] [Abstract][Full Text] [Related]
40. Retargeting Oncolytic Vesicular Stomatitis Virus to Human T-Cell Lymphotropic Virus Type 1-Associated Adult T-Cell Leukemia.
Betancourt D; Ramos JC; Barber GN
J Virol; 2015 Dec; 89(23):11786-800. PubMed ID: 26378177
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
